← USANA HEALTH SCIENCES INC
| Annual Trend | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net earnings | $62.5m |
$126.2m
+101.85%
|
$100.5m
-20.36%
|
— | $124.7m |
$116.5m
-6.54%
|
$63.8m
-45.25%
|
$42.1m
-34.06%
|
— | $11.5m | — | |
| Net Income (Loss) Attributable to Parent | $62.5m |
$126.2m
+101.85%
|
$100.5m
-20.36%
|
$124.7m
+24.01%
|
— | $69.3m |
$63.8m
-8.02%
|
$42.0m
-34.11%
|
$10.8m
-74.40%
|
— | — | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $62.5m | $126.2m | $100.5m | $124.7m | — | $69.3m | $63.8m | $42.1m | $11.5m | — | — | |
| Depreciation, Depletion and Amortization | $16.1m | $16.8m | $14.7m | $13.7m | $13.7m | $13.4m | $12.7m | $14.5m | $32.6m | $32.6m | $39.2m | |
| Depreciation | $14.5m | $15.2m | $13.1m | $12.2m | $13.7m | $11.4m | $10.9m | $13.2m | $13.8m | $32.6m | $39.2m | |
| Amortization of Intangible Assets | $1.5m | $1.5m | $1.4m | $1.3m | — | $1.7m | $1.8m | $1.5m | $19.3m | — | — | |
| Deferred Income Tax Expense (Benefit) | $19.3m | $699k | ($3.6m) | ($2.5m) | — | ($6.9m) | ($2.7m) | ($6.7m) | ($7.1m) | — | ($6.4m) | |
| Deferred income taxes | — | $699k | ($3.6m) | — | ($2.4m) | ($3.0m) | ($2.7m) | ($6.7m) | — | ($7.1m) | ($6.4m) | |
| Share-based Payment Arrangement, Noncash Expense | $15.5m | $15.0m | $15.5m | $14.4m | — | $13.3m | $14.6m | $14.6m | $13.8m | — | $14.4m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | $316k | $809k | $2.0m | $2.4m | — | $4.7m | $3.1m | $3.2m | $2.3m | — | — | |
| Share-based Payment Arrangement, Expense | $15.5m | $15.0m | $15.6m | — | — | — | — | $14.8m | $14.0m | — | $14.4m | |
| Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount | — | — | — | $0 | — | $0 | $0 | $0 | $0 | $7.0m | — | |
| Goodwill and Intangible Asset Impairment | — | — | — | — | — | — | — | $0 | $7.0m | — | — | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | — | $0 | $0 | $0 | $6.5m | — | $9.7m | |
| Impairment of Intangible Assets, Finite-lived | — | — | — | — | — | — | — | $0 | $0 | — | — | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | $0 | $0 | $0 | $0 | — | $0 | $0 | $0 | $0 | — | — | |
| Nonoperating Income (Expense) | $2.1m | $3.2m | $4.3m | $1.5m | — | $1.0m | $9.4m | $10.0m | $4.1m | — | — | |
| Other Nonoperating Income (Expense) | ($3k) | ($1.2m) | ($335k) | ($571k) | — | ($2.6m) | $7k | ($1.0m) | $2.5m | — | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Inventories | ($6.1m) | $23.1m | ($13.0m) | $16.8m | — | ($21.9m) | ($2.4m) | $2.1m | $34.7m | — | ($23.2m) | |
| Inventory Write-down | — | — | — | — | — | $6.1m | $2.6m | $1.9m | $2.7m | $2.7m | — | |
| Inventories | $6.1m | ($23.1m) | $13.0m | — | ($16.8m) | ($10.5m) | $2.4m | ($2.1m) | — | ($34.7m) | ($23.2m) | |
| Increase (Decrease) in Accounts Payable | $3.0m | ($1.7m) | $1.8m | $6.1m | $6.1m | ($2.7m) | ($428k) | ($1.3m) | $5.2m | $5.2m | $1.8m | |
| Accrued purchases of property and equipment | $109k | $195k | $998k | — | $375k | $383k | $117k | $42k | — | $1k | — | |
| Accrued excise tax for repurchase of common stock | — | — | — | — | — | $0 | $54k | $39k | — | $231k | — | |
| Prepaid expenses and other assets | $5.0m | ($1.6m) | $7.2m | — | ($5.2m) | ($2.3m) | $110k | ($2.9m) | — | $621k | — | |
| Other liabilities | ($6.5m) | $18.7m | ($30.8m) | — | $16.5m | ($11.5m) | ($30.0m) | ($6.7m) | — | ($14.2m) | — | |
| Restricted cash included in other assets | $3.1m | $2.9m | $2.9m | — | — | $2.9m | $2.8m | $2.7m | — | $2.9m | — | |
| Net Cash Provided by (Used in) Operating Activities | $123.8m |
$152.1m
+22.89%
|
$126.7m
-16.69%
|
$160.4m
+26.57%
|
$160.4m
0.00%
|
$103.9m
-35.22%
|
$70.6m
-32.01%
|
$61.0m
-13.66%
|
$22.3m
-63.36%
|
$22.3m
0.00%
|
$16.6m
-25.61%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $13.2m | $11.4m | $16.6m | $15.1m | ($15.1m) | $10.4m | $14.5m | $10.1m | $13.8m | ($13.8m) | ($13.7m) | |
| Gain (Loss) on Disposition of Property Plant Equipment | ($18k) | ($1.8m) | ($84k) | ($191k) | $6k | ($141k) | ($10k) | ($1k) | $2.1m | $3.9m | $13k | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | — | $0 | $6.5m | $0 | $203.3m | $0 | $0 | $0 | |
| Net Cash Provided by (Used in) Investing Activities | ($12.9m) | ($69.0m) | $47.5m | ($34.0m) | ($34.0m) | ($12.4m) | ($12.0m) | ($213.1m) | ($10.1m) | ($10.1m) | ($8.8m) | |
| Cash flows from financing activities: | ||||||||||||
| Borrowings on line of credit | $3.5m | $0 | $5.0m | — | $60.0m | $11.0m | $1.5m | $23.7m | — | $17.6m | — | |
| Payments for Repurchase of Common Stock | $50.0m | $105.4m | $150.0m | $57.0m | — | $25.4m | $11.6m | $9.4m | $27.5m | — | — | |
| Repurchase of common stock | ($50.0m) | ($105.4m) | ($150.0m) | — | ($57.0m) | ($177.8m) | ($11.6m) | ($9.4m) | — | ($27.5m) | — | |
| Net Cash Provided by (Used in) Financing Activities | ($50.3m) |
($105.3m)
-109.23%
|
($152.1m)
-44.43%
|
($59.4m)
+60.91%
|
($59.4m)
0.00%
|
($30.1m)
+49.38%
|
($14.2m)
+52.68%
|
$9.6m
+167.10%
|
($40.6m)
-525.03%
|
($40.6m)
0.00%
|
($29.8m)
+26.66%
|
|
| Net increase (decrease) in cash, cash equivalents, and restricted cash | $71.6m | ($33.3m) | $20.5m | — | $78.2m | ($72.3m) | $41.9m | ($148.7m) | — | ($23.3m) | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | ($33.3m) | $20.5m | $78.2m | — | $47.7m | $41.9m | ($148.7m) | ($23.3m) | — | $160.4m | |
| Cash, cash equivalents, and restricted cash at beginning of period | — | $217.2m | $237.7m | — | $315.9m | $243.7m | $333.2m | $184.5m | — | $161.2m | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $217.2m | $237.7m | $315.9m | — | $291.3m | $333.2m | $184.5m | $161.2m | — | $160.4m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | ($11.1m) | ($1.7m) | — | — | — | — | — | — | — | $5.3m | |
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | — | ($11.1m) | ($1.7m) | — | $11.3m | $2.1m | ($2.5m) | ($6.2m) | — | $5.1m | $5.3m | |
| Total cash, cash equivalents, and restricted cash | $250.5m | $217.2m | $237.7m | — | $315.9m | $243.7m | $333.2m | $184.5m | — | $161.2m | — | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | — | — | — | — | — | — | — | — | — | — | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $16k | $6k | $11k | $711k | $711k | $49k | $68k | $76k | $663k | $663k | — | |
| Income Taxes Paid, Net | — | — | — | — | — | — | — | $40.4m | $37.2m | — | — | |
| Additional Financial Items | ||||||||||||
| Goodwill | $17.4m | $16.8m | $16.6m | $17.4m | — | $17.4m | $17.1m | $144.2m | $138.0m | — | $9.7m | |
| Income Tax Expense (Benefit) | $72.1m | $65.3m | $50.0m | $53.3m | — | $39.3m | $38.7m | $34.3m | $30.1m | — | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | $262k | $281k | $842k | — | — | |
| Investment Income, Interest | $2.2m | $4.4m | $4.7m | $2.5m | — | $3.8m | $9.6m | $11.3m | $2.4m | — | — | |
| Operating Expenses | $735.4m | $800.2m | $727.2m | $749.0m | — | $697.1m | $651.2m | $627.0m | $687.0m | — | — | |
| Operating Lease, Expense | — | — | $9.6m | $11.2m | — | $8.3m | $8.8m | $8.2m | $8.3m | — | — | |
| Right-of-use asset reduction | — | — | $8.3m | — | $8.8m | $9.2m | $7.7m | $7.7m | — | $7.1m | — | |
| Equity-based compensation expense | $15.5m | $15.0m | $15.5m | — | $14.4m | $14.3m | $14.6m | $14.6m | — | $13.8m | — | |
| Proceeds from the settlement of net investment hedges | — | $739k | $1.9m | — | $1.9m | $4.6m | $3.8m | $1.1m | — | $0 | — | |
| Payments for net investment hedge | — | $0 | ($1.7m) | — | ($1.1m) | ($1.6m) | ($1.3m) | ($870k) | — | ($1.1m) | — | |
| Proceeds from acquisition working capital adjustment | — | — | — | — | — | — | $0 | $0 | — | $865k | — | |
| Payments on line of credit | ($3.5m) | $0 | ($5.0m) | — | ($60.0m) | ($11.0m) | ($750k) | ($1.5m) | — | ($26.6m) | — | |
| Payments related to tax withholding for net-share settled equity awards | ($316k) | ($809k) | ($2.0m) | — | ($2.4m) | ($3.6m) | ($3.1m) | ($3.2m) | — | ($2.3m) | — | |
| Distributions to redeemable noncontrolling interest | — | — | — | — | — | — | $0 | $0 | — | ($1.7m) | — | |
| Payments for contingent consideration | — | — | — | — | — | $0 | ($338k) | $0 | — | $0 | — | |
| Cash and cash equivalents | $247.1m | $214.3m | $234.8m | — | $311.9m | $239.8m | $330.4m | $181.8m | — | $158.4m | $182.4m | |
| Right-of-use assets obtained in exchange for lease obligations | — | $0 | $33.3m | — | $6.6m | $5.3m | $5.7m | $12.5m | — | $8.6m | — | |
| Net working capital adjustment receivable | — | — | — | — | — | $0 | $0 | $778k | — | $0 | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.